K2 Principal Fund, L.P. Bristol Myers Squibb CO Call Options Transaction History

K2 Principal Fund, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $446,200 - $493,400	-10,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $451,200 - $538,000	10,000 New	10,000 $477,000
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $37.7 Million - $43.5 Million	-630,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $9.59 Million - $10.5 Million	160,000 Added 34.04%	630,000 $38.6 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $26 Million - $30 Million	470,000	470,000 $30 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.